CURE vs VIG

ACURE

BVIG

Measures won1–5VIG wins · of 6 · 5Y

$10,000 · 5Y$16,331VIG · CURE $14,647

Lowest cost0.04%VIG · $4 on $10k

Most income1.49%VIG · $149 on $10k

Smallest drop−7.9%VIG · worst fall in 1Y

Held in common13.7%CURE and VIG

CURE

VIG

Direxion Daily Healthcare Bull 3X ETF · $201MVanguard Dividend Appreciation ETF · $109B

+29.9%3 years · per year$21,930 · $16,814+18.9%

+7.9%5 years · per year$14,647 · $16,331+10.3%

0.94%Expense ratio$94 · $4 on $10k · lower wins0.04%

0.76%12-mo yield$76 · $149 on $10k1.49%

−31.1%Worst dropSmaller wins−7.9%

49.4%VolatilityLower wins10.8%

1–5VIG wins

$10,000 · 5 yearsOne scale

Shared top holdingsCURE · VIG

3.3%LLY4.1%

1.9%JNJ2.8%

1.5%ABBV2.0%

1.1%MRK1.6%

Held in common13.7%

End-of-day Nov 5, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

Both

5Y2 funds

#			Trend
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk		0.04%	1.49%	−3.3%	+12.5%	+15.2%	+18.9%	+10.3%	−7.9%	$109.1B
2	ACURE	Direxion Daily Healthcare Bull 3X ETFRead Desk		0.94%	0.76%	−7.8%	+50.8%	+81.4%	+29.9%	+7.9%	−31.1%	$201M

End-of-day Nov 5, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Both

5Y2 funds

#			Trend
1	BVIG	Vanguard Dividend Appreciation ETFRead Desk		0.04%	1.49%	−3.3%	+12.5%	+15.2%	+18.9%	+10.3%	−7.9%	$109.1B
2	ACURE	Direxion Daily Healthcare Bull 3X ETFRead Desk		0.94%	0.76%	−7.8%	+50.8%	+81.4%	+29.9%	+7.9%	−31.1%	$201M

End-of-day Nov 5, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

CURE vs VIG

CURE

Direxion Daily Healthcare Bull 3X

$14,647

VIG

Vanguard Dividend Appreciation

$16,331

MeasureCUREVIG

Fee0.94%0.04%

Cost on $10k a year$94$4

Yield0.76%1.49%

5 years, per year+7.9%+10.3%

3 years, per year+29.9%+18.9%

Worst drop · 1Y−31.1%−7.9%

Volatility · 1Y49.4%10.8%

5–1measures won
VIG first

13.7%

holdings shared

Nov 5, 2026 · $10,000 five years ago, dividends reinvested

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

DGRO vs VIG

YTD

iSharesDGRO

+17.2%

VIGVanguard

+12.5%

+17.2%Year to date+12.5%

1.9%Yield1.5%

$46.1BAssets$109B

2–0DGRO wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.1BAssets$46.1B

2–0JEPQ wins

End-of-day Nov 5, 2026

Overlap: CURE, VIG

Today

13.7%most shared, CURE and VIG

CUREVIG

CURE—13.7%

VIG13.7%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Income After Fees on $10,000

$145most kept, VIG

VIG$149 − $4 = $145

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee